Perjeta

Active Ingredient(s): Pertuzumab
FDA Approved: * June 8, 2012
Pharm Company: * GENENTECH
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Perjeta Overview

Pertuzumab (also called 2C4, trade name Perjeta)[1] is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.[2] Side effects in more than half the people taking it include diarrhea, hair loss, and loss of neutrophils; more than 10% experience loss of red blood cells, hypersensitivity or aller...

Read more Perjeta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pertuzumab

Recent Perjeta Forums: RSS Feed

Side Effects of Perjeta?

Has anyone experienced cold like symptoms for an extended length of time after their last Perjeta infusion? I have had a stuffy nose since last May. My last infusion was in October. People have suggested it might be allergies but these aren't the normal symptoms of the allergies I used to have. The syptoms don't come and go. It has been every day. My Oncologist doesn't believe Perjeta has anything to do with my condition. Any help would be appreciated. Thank you ## Hello, Janine! How are you? It would be very unusual for side effects from the Perjeta to linger that long after your last infusion. Our bodies do change with time, so it could very well be a new allergy or an existing one that has gotten worse. Have you tried consulting an allergist? ## Thank you so much for your...

Updated

Possible Dosages for this and Related Drugs:

Pertuzumab
  • Vial: 420mg/14ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Perjeta: (1 result)

Sorted by National Drug Code
  • 50242-145 Perjeta 30 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc.

Other drugs which contain Pertuzumab or a similar ingredient: (1 result)

Related Perjeta Topics:

Side Effects of Perjeta?
Has anyone experienced cold like symptoms for an extended length of time after their last Perjeta infusion? I have had a... 2 replies






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA